Event Brief
Jul 9, 2026 at 6:00 AM ET
AstraZeneca stock drops 9% after heart drug trial
By The BriefBrief
AstraZeneca shares fell about 9% after a late-stage heart drug trial missed its primary target.
WHO: AstraZeneca
WHAT: A late-stage heart drug trial missed its primary endpoint, prompting a sharp stock drop
WHEN: Jul 9, 2026 at 4:53 AM ET
WHERE: United Kingdom
WHY: Cause not yet established.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Early voting begins July 17 for Aug. 6 election
Early Voting
Jul 9, 2026 at 6:00 AM ET
Grainger 4-H Wildlife Team Competes at State
4-H
Jul 9, 2026 at 6:00 AM ET
Pasco woman arrested for DUI after crash
Dui
Jul 9, 2026 at 6:00 AM ET
Dangerous heat builds; low rain chances today
Heat
Jul 9, 2026 at 6:00 AM ET
Page 13358 of 21397
Same format. Every time.
Continue reading — sign in or create a free account with
